PCSK9 and metabolic syndrome: Therefore, medications designed to reduce their levels, such as statins [123] or proprotein convertase subtilisin/kexin type 9 (PCSK-9) inhibitors [124], may be beneficial not only in dyslipidemia treatment but also in the prevention of tauopathies.